What you need to know

On Sept. 22, 2025, Omnicare — a subsidiary of CVS Health — announced its plans to initiate a voluntary, court-supervised Chapter 11 bankruptcy protection. The filing is intended to address a nearly $1 billion legal judgement facing the company and provide a path to restructure amid ongoing financial challenges. There is no impact on Prime Therapeutics' (Prime) plans.

Overview

Omnicare has filed for Chapter 11 bankruptcy protection following a summer federal court ruling that directed the company to pay close to $950 million in penalties related to a lawsuit. Prime is monitoring the situation.

Omnicare primarily provides pharmacy and drug management services to long-term care facilities, assisted living centers and other senior care providers. 

During the court-supervised process, Omnicare has emphasized it will continue to fill prescriptions and serve long-term care facilities during the process and without disruption. Patients and long-term care facilities should continue to receive prescriptions and clinical services from Omnicare as usual.

Prime's response and next steps

There is no impact on Prime plans. Prime is currently engaged in ongoing communication with Omnicare, which has reaffirmed its commitment to maintaining a consistent member experience throughout the proceedings. We will continue to closely monitor the situation and share relevant updates as they become available. 

Questions

Please reach out to your Prime account team representative. Pharmacy directors should contact their dedicated network clinical service manager with questions.